Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.124.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XYNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XYNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GP.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GP.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.469NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.80 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.80 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.80 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.8 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.43.8 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.8 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.128 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.128 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.128 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.220NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.220NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.220NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.58NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.58NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used